About this episode
Traders expect the Federal Reserve to pause future rate rises, Bristol-Myers Squibb's $90bn takeover of Celgene signals a big year for pharma M&A and agricultural researchers discover a genetic breakthrough in crop growth. Then, why EU officials are looking to toughen scrutiny of potential security risks with Chinese technology companies. Hosted on Acast. See acast.com/privacy for more information.